Baltic Amber - project phase 2
PRETECHinf


Based on the activities of project phase 1 (April 2011 to November 2012) the second Baltic Amber (Baltic alliance against multi-resistant bacteria) project phase was launched in the end of 2013. It aims at improving the treatment of implant-associated infections in orthopedic surgery.

An international consortium has been formed to cooperate in this area. It has, amongst others, prepared and submitted an EU HORIZON 2020/PHC-16 proposal for an international multi-center study in October 2014. The project is called:


"PRETECHinf: Preventive Regenerative Technology Combating Deep Bone and Joint Infections "
“Technological innovations in regenerative medicine with new diagnostic tools, new treatment algorithms and therapeutic biomaterials combatting increased bacterial resistance in emerging bone and joint infections; Evaluating patient outcome and cost effectiveness in national implant registers with focus on societal and human implications"


Participanting parties

  • Charité Universitätsmedizin Berlin, Germany

  • -Prof. Andrej Trampuz

  • Galeazzi di Milano, Italy

  • - Dr. Carlo L. Romanò
    - Prof. Lorenzo Drago





  • Universität Rostock, Germany

  • - Prof. Rainer Bader
    - Prof. Wolfram Mittelmeier



Project management
  • Dr Gudrun Mernitz, BioCon Valley, Germany


For additional project information please refer to the » project leaflet.

Working plan
Project work will be done mainly by exchange and discussion of work papers. The process is coordinated by the HICARE project office located at the Greifswald office of project partner BioCon Valley®.

In addition, four workshops were held until submission of the proposal in October 2014 for direct exchange between partners:
  • February 21-22, 2014, Lund

  • June 6, 2014, London

  • July 31-August 1, 2014, Ystad

  • September 12, 2014, Utrecht

Initiated by



Supported by
Gewinner im Wettbewerb
"Gesundheitsregionen der Zukunft"